Similarly, additionally to augment CD8+ T cell infiltration, the association of PARPi olaparib and PD-L1 blockade induced complete tumor regression in multiple immunocompetent small cell lung carcinoma (SCLC) mice models [133]. Here, CD274 is linked to small cell lung carcinoma.